Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters











Publication year range
1.
Ann Hepatol ; 7(2): 163-7, 2008.
Article in English | MEDLINE | ID: mdl-18626436

ABSTRACT

A one year eight month old male child and his nine month old female sibling were presented with Growth retardation, abdominal distension, doll-like faces, hepatomegaly, phosphaturia, proximal renal tubular dysfunction. The elder sibling also presented with glucosuria, hyperglycemia, hypoinsulinemia. The younger one later presented with galactosemia. Biopsy of liver on these two patients revealed the accumulation of glycogen in hepatocytes.


Subject(s)
Growth Disorders/diagnosis , Hepatomegaly/diagnosis , Hypophosphatemia, Familial/diagnosis , Biopsy , Female , Glycogen/metabolism , Growth Disorders/metabolism , Growth Disorders/pathology , Hepatocytes/metabolism , Hepatocytes/pathology , Hepatomegaly/metabolism , Hepatomegaly/pathology , Humans , Hypophosphatemia, Familial/metabolism , Hypophosphatemia, Familial/pathology , Infant , Liver/metabolism , Liver/pathology , Male , Syndrome
2.
Pediatr Dermatol ; 22(1): 48-54, 2005.
Article in English | MEDLINE | ID: mdl-15660898

ABSTRACT

The epidermal nevus syndrome is the association of epidermal nevi with abnormalities in other organ systems, most commonly the central nervous system, the skeletal system, and the eyes. We present a patient with epidermal nevus syndrome associated with hypophosphatemic vitamin D-resistant rickets and multiple adnexal and spindle cell tumors.


Subject(s)
Hypophosphatemia, Familial/metabolism , Neoplasms, Adnexal and Skin Appendage/pathology , Neoplasms, Multiple Primary/pathology , Nevus, Epithelioid and Spindle Cell/pathology , Skin Neoplasms/pathology , Child , Female , Humans , Hypophosphatemia/metabolism , Hypophosphatemia, Familial/complications , Neoplasms, Adnexal and Skin Appendage/complications , Nevus , Nevus, Epithelioid and Spindle Cell/complications , Nevus, Pigmented , Skin , Skin Neoplasms/complications , Syndrome
3.
J Pediatr ; 127(3): 395-402, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7658269

ABSTRACT

OBJECTIVE: To evaluate the effects of treatment with recombinant human growth hormone (rhGH) on growth, mineral metabolism, and bone density in children with renal hypophosphatemic rickets (RHR). DESIGN: Long-term rhGH treatment combined with conventional therapy with 1,25-dihydroxyvitamin D3 plus inorganic phosphate salts. SETTING: Endocrine unit, department of pediatrics, university hospital. SUBJECTS: Twelve patients (5 boys; age range 4.6 to 12.5 years, median 7.0 years) were subdivided into two groups of six patients on the basis of the median of height z score (-2.41) and the median bone age/statural age (BA/SA) ratio (1.23). Group A included patients with a severe degree of short stature (height z score -3.4 +/- 0.5) (mean +/- SD) and altered BA/SA ratio (1.26 +/- 0.08); group B included patients with a lesser degree of short stature (height z score -2.1 +/- 0.6, p < 0.001 vs group A) and more normal BA/SA ratio (1.04 +/- 0.15, p < 0.01 vs group A). INTERVENTION: Group A received rhGH treatment (0.6 IU/kg per week subcutaneously) combined with conventional therapy; group B received conventional therapy alone. MEASUREMENTS: Height, growth velocity, predicted adult height, serum values of calcium, phosphate, bone alkaline phosphatase isoenzyme, osteocalcin, propeptides of type I and type III procollagen, intact parathyroid hormone, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and urinary calcium/urinary creatinine ratio and tubular maximum for phosphate reabsorption normalized to the glomerular filtration rate (TmP/GFR), as well as radial bone density, were measured at baseline and for 3 years. RESULTS: Height z score, growth velocity z score, predicted adult height, serum values of phosphate, bone alkaline phosphatase isoenzyme, osteocalcin, propeptides of type I and type III procollagen, intact parathyroid hormone 1,25-dihydroxyvitamin D, and TmP/GFR, as well as radial bone density, improved significantly only in group A. Serum calcium and 25-hydroxyvitamin D, and urinary calcium/urinary creatinine ratio did not change in either group. CONCLUSIONS: Long-term rhGH administration may benefit growth, phosphate retention, and bone density in patients with RHR, without evidence of side effects.


Subject(s)
Bone Density/drug effects , Bone and Bones/drug effects , Growth Hormone/therapeutic use , Growth/drug effects , Hypophosphatemia, Familial/drug therapy , Minerals/metabolism , Bone and Bones/metabolism , Calcitriol/therapeutic use , Child , Child, Preschool , Drug Therapy, Combination , Female , Growth Hormone/adverse effects , Humans , Hypophosphatemia, Familial/metabolism , Linear Models , Male , Phosphates/therapeutic use , Prospective Studies , Recombinant Proteins/adverse effects , Recombinant Proteins/therapeutic use , Statistics, Nonparametric , Time Factors
4.
Bone Miner ; 12(2): 91-100, 1991 Feb.
Article in English | MEDLINE | ID: mdl-2015415

ABSTRACT

X-linked hypophosphatemic rickets (XLH) is characterized by inadequate skeletal mineralization. The bone mineral density (BMD) of the radius shaft and the lumbar spine was determined in 13 children with XLH. Ten patients were on treatment, whereas three patients had discontinued treatment 20-32 months prior to this study. Two of them had radiological evidence of rickets. The radius shaft BMD was significantly diminished: Z score was -1.33 +/- 0.89 (P less than 0.001), while the BMD of lumbar spine was significantly augmented (Z score +1.95 +/- 1.17, P less than 0.001). A positive correlation was found between the Z scores for the BMD of the radius shaft and spine. The two patients with overt rickets had lower radius shaft BMD values and a lesser increment of BMD of the spine. The BMD deficit of cortical bone may be related to the lack of efficacy of the treatment and/or to an intrinsic defect of the bone on this disease. On the other hand, the augmented BMD of the lumbar spine might reflect the overabundance of partially mineralized osteoid. The determination of the BMD of the radius shaft by SPA was a sensitive method for detecting abnormalities of the bone mass in XLH patients under treatment without radiological signs of rickets.


Subject(s)
Bone Density , Hypophosphatemia, Familial/metabolism , Rickets/metabolism , Absorptiometry, Photon , Adolescent , Alkaline Phosphatase/blood , Calcium/blood , Child , Child, Preschool , Female , Genetic Linkage , Humans , Lumbar Vertebrae/chemistry , Male , Phosphates/blood , Radius/chemistry , Rickets/genetics , X Chromosome
6.
HU rev ; 14(3): 59-65, set.-dez. 1987.
Article in Portuguese | LILACS | ID: lil-77445

ABSTRACT

Os autores relatam umc aso de raquitismo hipocalcêmico dependente da vitamina D e comentam sobre o metabolismo da vitamina D; os aspectos clínicos, laboratoriais e terapêuticos, abordando as caracterísicas do raquitismo carencial e do hipocalcêmico dependente da vitamina D tipo I e II


Subject(s)
Infant , Humans , Male , Hypophosphatemia, Familial/metabolism , Calcium/metabolism , Vitamin D/metabolism
8.
J Pediatr ; 94(5): 729-35, 1979 May.
Article in English | MEDLINE | ID: mdl-221630

ABSTRACT

Rickets with alopecia, an inborn error of vitamin D metabolism, is described in two sisters. The rachitic disorder began during the first year of life and was refractory to 50,000 IU of vitamin D2/day. Surprisingly, both children had marked elevations in serum concentrations of 1,25-(OH)2D. Although the molecular basis for this disorder is not evident to date, intestinal end-organ unresponsiveness to exceedingly high levels of 1,25-(OH)2D was present, in addition to hyporesponsiveness of bone to these high levels of the hormone, since normocalcemia was maintained despite elevated serum levels of PTH. Therapy with oral 1,25-(OH)2D3 failed to reverse the disorder, but oral phosphorus supplements resulted in significant radiographic and clinical improvement.


Subject(s)
Alopecia/complications , Hypophosphatemia, Familial/complications , Metabolism, Inborn Errors/complications , Vitamin D/metabolism , Alopecia/genetics , Alopecia/metabolism , Calcium/metabolism , Child , Child, Preschool , Dihydroxycholecalciferols/blood , Dihydroxycholecalciferols/therapeutic use , Female , Humans , Hypophosphatemia, Familial/genetics , Hypophosphatemia, Familial/metabolism , Metabolism, Inborn Errors/genetics , Metabolism, Inborn Errors/metabolism , Phenotype , Phosphorus/metabolism , Phosphorus/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL